Genvor Acquires Founder’s Synthetic Peptide IP and Research Data
Genvor entered into an agreement with founder and Chief Scientific Officer Jesse Jaynes to acquire rights to synthetic and designed peptide sequences, including approximately 9,000 antimicrobial peptides, plus related research data and design materials.